Question · asked by 1 review

Erythromycin plus nasogastric tube lavage vs no intervention/placebo plus nasogastric tube lavage: All‐cause mortality

Population
people with acute UGIH
Intervention
Erythromycin plus nasogastric tube lavage
Comparison
no intervention/placebo plus nasogastric tube lavage
Outcome
All‐cause mortality

It is very uncertain whether erythromycin plus nasogastric tube lavage changes all‐cause mortality compared with no intervention/placebo plus nasogastric tube lavage (very low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Erythromycin plus nasogastric tube lavage vs no intervention/placebo plus nasogastric tube lavage
All‐cause mortality · people with acute UGIH
It is very uncertain whether erythromycin plus nasogastric tube lavage changes all‐cause mortality compared with no intervention/placebo plus nasogastric tube lavage (very low certainty).
Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage (2023) · Cochrane Headline outcomes only
no estimate extracted3 studies · 238 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage
2023 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.